Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Globigen is a veterinary dietary supplement and gut-health support product developed by EW Nutrition and marketed by Navana Pharmaceuticals. It is formulated to stabilize the water and electrolyte balance, support physiological digestion, and promote gut health in young livestock, particularly newborn calves, lambs, and kids. The product contains natural egg immunoglobulins (IgY) derived from egg yolk, which bind and neutralize specific diarrhea-causing pathogens in the intestinal tract, preventing them from attaching to the intestinal wall. Additionally, Globigen is enriched with dextrose for energy, essential electrolytes (sodium chloride, sodium bicarbonate, potassium chloride) to prevent dehydration, yeast products to support stable gut flora, and a vitamin premix (Vitamins A, D3, and E) to enhance overall immune function and daily body weight gain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Globigen.